Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

PD Davis is the salaried founder, CEO and owner of Quanta BioDesign, Ltd, the company that invented the dPEG^® process technology, which also develops, manufactures and markets products based on this core-process technology. Many of the studies referenced in this editorial article use products purchased from Quanta BioDesign, Ltd, or from companies who distribute the same. However, there are no financial interests in the specific projects related to the studies referenced herein, nor are there any financial gains by referencing the aforesaid. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.